BE886973A - Compositions pharmaceutiques a liberation controlee de potassium - Google Patents

Compositions pharmaceutiques a liberation controlee de potassium

Info

Publication number
BE886973A
BE886973A BE0/203409A BE203409A BE886973A BE 886973 A BE886973 A BE 886973A BE 0/203409 A BE0/203409 A BE 0/203409A BE 203409 A BE203409 A BE 203409A BE 886973 A BE886973 A BE 886973A
Authority
BE
Belgium
Prior art keywords
pharmaceutical compositions
controlled release
release potassium
potassium pharmaceutical
controlled
Prior art date
Application number
BE0/203409A
Other languages
English (en)
Inventor
I Lippmann
S D Popli
L G Miller
L G Bell
Original Assignee
A H Robins Cy Inc Etat De Virg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A H Robins Cy Inc Etat De Virg filed Critical A H Robins Cy Inc Etat De Virg
Publication of BE886973A publication Critical patent/BE886973A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE0/203409A 1980-06-13 1981-01-06 Compositions pharmaceutiques a liberation controlee de potassium BE886973A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/159,335 US4259315A (en) 1980-06-13 1980-06-13 Controlled release potassium dosage form

Publications (1)

Publication Number Publication Date
BE886973A true BE886973A (fr) 1981-05-04

Family

ID=22572135

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/203409A BE886973A (fr) 1980-06-13 1981-01-06 Compositions pharmaceutiques a liberation controlee de potassium

Country Status (13)

Country Link
US (1) US4259315A (fr)
JP (1) JPS5714525A (fr)
AU (1) AU544965B2 (fr)
BE (1) BE886973A (fr)
CA (1) CA1135624A (fr)
CH (1) CH648206A5 (fr)
DE (1) DE3100808A1 (fr)
FR (1) FR2484254A1 (fr)
GB (1) GB2077587B (fr)
IL (1) IL61817A (fr)
IT (1) IT1212512B (fr)
NL (1) NL192430C (fr)
PH (1) PH15605A (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1148784B (it) * 1980-04-09 1986-12-03 Eurand Spa Procedimento per la preparazione di microcapsule in un veicolo liquido
DK152744C (da) * 1982-08-13 1988-10-31 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
DE3306250A1 (de) * 1983-02-23 1984-08-23 Basf Ag, 6700 Ludwigshafen Sphaerische einkristalle fuer pharmazeutische zwecke
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
DE3586600T2 (de) * 1984-02-10 1993-02-18 Benzon Pharma As Dosierungsform eine vielzahl mit einer diffusionshuelle ueberzogener einheiten enthaltend.
WO1986003121A1 (fr) * 1984-11-27 1986-06-05 Sawruk Stephen D Produit de recalcification des tissus
US4851392A (en) * 1985-02-05 1989-07-25 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4843098A (en) * 1985-02-05 1989-06-27 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4790991A (en) * 1985-02-05 1988-12-13 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4818539A (en) * 1985-02-05 1989-04-04 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
IE59066B1 (en) * 1985-02-19 1993-12-15 Key Pharma Controlled release potassium chloride
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US5095151A (en) * 1985-05-21 1992-03-10 American Home Products Corporation Preparation of propranolol hydrochloride macrocrystals
US4764375A (en) * 1985-09-11 1988-08-16 Kv Pharmaceutical Company Sachet drug delivery system
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US4795642A (en) * 1986-05-01 1989-01-03 Pharmacaps, Inc. Gelatin-encapsulated controlled-release composition
FR2602423B1 (fr) * 1986-08-08 1989-05-05 Ethypharm Sa Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
US4822619A (en) * 1987-02-18 1989-04-18 Ionor, Inc. Controlled release pharmaceutical preparation containing a gastrointestinal irritant drug
US5932252A (en) * 1988-10-21 1999-08-03 The Regents Of The University Of California Method and composition for treatment of osteoporosis
US5498428A (en) * 1988-10-21 1996-03-12 The Regents Of The University Of California Treatment of hypertension by oral administration of potassium bicarbonate
HU201869B (en) * 1988-12-30 1991-01-28 Egyt Gyogyszervegyeszeti Gyar Process for producing microcapsules of quick dissolving active component
US5077051A (en) * 1990-04-10 1991-12-31 Warner-Lambert Company Sustained release of active agents from bioadhesive microcapsules
US5252337A (en) * 1991-06-25 1993-10-12 Eurand America, Inc. Controlled release calcium channel blocker microcapsules
US5422122A (en) * 1992-08-04 1995-06-06 Eurand America, Incorporated Controlled release potassium chloride tablet
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US5674529A (en) * 1995-06-06 1997-10-07 Church & Dwight Co., Inc. Alkalinizing potassium salt controlled release preparations
US5895662A (en) * 1997-12-31 1999-04-20 Meyer; Martha C. Meat product pet medicine capsule
DE69900977T2 (de) 1998-04-09 2002-11-14 Eurand Int Benetzbare mikrokapseln, die mit ethylcellulose überzogene kerne besitzen
US6506401B1 (en) 1999-01-28 2003-01-14 H. J. Heinz Company Filled edible product, and system and method for production of a filled edible product
DE19913606A1 (de) * 1999-03-25 2000-09-28 Basf Ag Pulverförmige Solubilisationshilfsstoffe für feste pharmazeutische Darreichungsformen
DE10011447A1 (de) * 2000-03-10 2001-09-20 Roehm Gmbh Dispersion mit nichtionischem Emulgator
AU2001257359A1 (en) 2000-04-27 2001-11-07 Verion Inc. Zero order release and temperature-controlled microcapsules and process for the preparation thereof
WO2001091730A1 (fr) 2000-05-31 2001-12-06 Drugtech Corporation Complement mineral
JP4689114B2 (ja) * 2000-11-02 2011-05-25 エーザイ・アール・アンド・ディー・マネジメント株式会社 ビタミンと加工大蒜を含有するカプセル剤
US6780437B2 (en) * 2001-10-23 2004-08-24 Upsher-Smith Laboratories, Inc. Coated potassium chloride granules and tablets
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
US7538652B2 (en) * 2006-08-29 2009-05-26 International Business Machines Corporation Electrical component tuned by conductive layer deletion
CA2700480A1 (fr) * 2007-09-28 2009-04-02 Lintec Corporation Preparation medicinale pour administration orale
US8974594B2 (en) * 2011-03-29 2015-03-10 Empire Technology Development Llc Microcapsule corrosion control in reinforced concrete
DE102017201095A1 (de) * 2017-01-24 2018-07-26 Henkel Ag & Co. Kgaa Tenside in Kapseln mit optimiertem Trübungspunkt

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3415758A (en) * 1960-03-09 1968-12-10 Ncr Co Process of forming minute capsules en masse
DE2224256C2 (de) * 1972-05-18 1985-05-23 Sanol-Arzneimittel Dr. Schwarz Gmbh, 4019 Monheim Arzneimittelzubereitung
JPS5112919A (en) * 1974-07-19 1976-01-31 Smith Kline French Lab Johoseisoseibutsuno seiho
GB1422193A (en) * 1974-07-26 1976-01-21 Smith Kline French Lab Pharmaceutical compositions
US4140756A (en) * 1976-06-10 1979-02-20 Mead Johnson & Company Film-coated matrix core tablet

Also Published As

Publication number Publication date
AU544965B2 (en) 1985-06-27
GB2077587B (en) 1983-10-12
FR2484254B1 (fr) 1983-06-10
FR2484254A1 (fr) 1981-12-18
IT1212512B (it) 1989-11-22
AU6589880A (en) 1981-12-24
GB2077587A (en) 1981-12-23
NL192430B (nl) 1997-04-01
JPH0260649B2 (fr) 1990-12-17
IL61817A0 (en) 1981-01-30
US4259315A (en) 1981-03-31
DE3100808A1 (de) 1982-01-07
CH648206A5 (fr) 1985-03-15
NL8100468A (nl) 1982-01-04
IT8167071A0 (it) 1981-01-22
CA1135624A (fr) 1982-11-16
DE3100808C2 (fr) 1990-07-26
PH15605A (en) 1983-02-28
IL61817A (en) 1983-11-30
JPS5714525A (en) 1982-01-25
NL192430C (nl) 1997-08-04

Similar Documents

Publication Publication Date Title
BE886973A (fr) Compositions pharmaceutiques a liberation controlee de potassium
FR2514642B1 (fr) Compositions pharmaceutiques a liberation retardee
BE883779A (fr) Compositions therapeutiques a liberation etalee
BE859288A (fr) Composition pharmaceutique a liberation etalee
GB2053681B (en) Sustained release pharmaceutical composition
FR2547498B1 (fr) Comprimes de naproxen et de naproxen sodique a liberation controlee
IT1114268B (it) Meccanismo per freno
IE792452L (en) Controlled release medicaments
DK500981A (da) Koblingsmekanisme
FR2512676B1 (fr) Composition a liberation commandee hydrodynamiquement equilibree
IT1144911B (it) Composizione farmaceutica a rilascio controllato contenente ibuprofen
GB2020388B (en) Dowel pin for dental casts
JPS56103110A (en) Sustained release medicinal composition
IL50175A0 (en) Sustained release pharmaceutical solid oral compositions
GB2020297B (en) Photopolymerization composition
AR216956A1 (es) Mecanismo de embrague
IT1142014B (it) Formulazioni a lento rilascio di ferormoni maccone
FR2604902B1 (fr) Compositions pharmaceutiques a liberation prolongee
BE882706A (fr) Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl
JPS56121560A (en) Slowly releasing perfume composition
SE446170B (sv) Hydraulisk hjelpkraftbroms
BE887468A (fr) Compositions pharmaceutiques contenant un derive de naphtyridine
JPS5571691A (en) Fluteesounding agent for fireworks
JPS54102361A (en) Drum for forming blister
JPS54101317A (en) Mechanism for releasing shutter

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: AMERICAN HOME PRODUCTS CORP.

Effective date: 20000131